AimMax Therapeutics

AimMax Therapeutics, Inc., located in the Research Triangle Park of North Carolina, USA, develops its research/discovery in collaboration with strategic partners. Focused primarily on anti-inflammatory and anti-infective therapies, the company engages in the research and development of biopharmaceuticals at various stages of development. The company's R&D strengths stem from extensive experience in basic and non-clinical research, translational medicine, clinical trial design, as well as regulatory and commercial strategy.